The Dermatology Market Outlook to 2011
Topics: Infectious Diseases, Dermatology
|
Executive Summary: Anti-Infectives: World Market, 2nd. Ed., Vol. I: Antifungals
Topics: Over-the-Counter Drugs, Prescription Drugs, Infectious Diseases
Regions: Global
|
Infectious Disease Diagnostics Markets in sub-Saharan Africa
Topics: AIDS, HIV & STDs, Drug Delivery, Infectious Diseases
Regions: Africa
|
Stakeholder Opinions: Respiratory Syncytial Virus (RSV) - A market yet to reach its full potential
Topics: Antibody Technologies, Infectious Diseases, Respiratory/Pulmonary
|
Commercial Insight: Antibacterials - Growth in resistance rates drives niche indications
Topics: Infectious Diseases
|
Report on China's Anti-fungal Drug Industry
Topics: Prescription Drugs, Infectious Diseases
Regions: China
|
Noninvasive Prenatal Diagnostics: How Will They Revolutionize the Industry?
Topics: Genomics, In Vitro Diagnostics, Clinical Guidelines/Best Practices, Ultrasonography, Infectious Diseases, Women's Health, Obstetrics/Gynecology
|
The Global Market for Antimicrobials and Antifungals: Challenging Resistance to 2016
Topics: Prescription Drugs, Infectious Diseases
Regions: Global
|
Stakeholder Insight: Respiratory Tract Infections in the USA - The Demise of Narrow-spectrum Antibiotics
Topics: Prescription Drugs, Infectious Diseases, Respiratory/Pulmonary
Regions: United States
|
Identifying Drug-Resistant Bacterial Infections: Opportunity and Activity in the Diagnostics Arena
Topics: In Vitro Diagnostics, Pharmaceuticals, Infectious Diseases
|
Antivirals
Topics: AIDS, HIV & STDs, Hepatitis, Pharmaceuticals, Prescription Drugs, Infectious Diseases
Regions: Global
|
The 2007-2012 Outlook for Antibacterial and Antiseptic Pharmaceuticals in the United States
Topics: General Pharmaceuticals, Infectious Diseases
|
The 2007-2012 Outlook for Anti-Infective Pharmaceutical Preparations Affecting Amebacides and Trichomonicides in the United States
Topics: Infectious Diseases
|
The 2007-2012 Outlook for Anti-Infective Pharmaceutical Preparations Affecting Anthelminics in the United States
Topics: Manufacturing, Packaging & Detailing, Infectious Diseases
|
The 2007-2012 Outlook for Antimalarial (plasmodicide) Pharmaceuticals in the United States
Topics: General Pharmaceuticals, Infectious Diseases
Regions: United States, Global
|
The 2007-2012 Outlook for Antitubercular Pharmaceuticals Excluding Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Preparations in the United States
Topics: General Pharmaceuticals, Infectious Diseases
Regions: United States
|
The 2007-2012 Outlook for Pharmaceutical Preparations for Human Use Affecting Parasitic and Ineffective Diseases Excluding Diagnostics in the United States
Topics: Infectious Diseases
|
The 2007-2012 Outlook for Pharmaceutical Preparations for Human Use Affecting Parasitic and Infectious Diseases Excluding Diagnostics in the United States
Topics: Manufacturing, Packaging & Detailing, Infectious Diseases
|
The 2007-2012 Outlook for Systemic Broad-And Medium-Spectrum Antibiotic Cephalosporins in the United States
Topics: General Pharmaceuticals, Manufacturing, Packaging & Detailing, Infectious Diseases
|
The 2007-2012 Outlook for Systemic Broad-And Medium-Spectrum Antibiotic Erythromycins in the United States
Topics: General Pharmaceuticals, Manufacturing, Packaging & Detailing, Infectious Diseases
|
The 2007-2012 Outlook for Systemic Broad-And Medium-Spectrum Antibiotic Pharmaceutical Preparations of Injectable, Semisynthetic Single Penicillins in the United States
Topics: General Pharmaceuticals, Infectious Diseases
|
The 2007-2012 Outlook for Systemic Broad-And Medium-Spectrum Antibiotic Pharmaceutical Preparations of Semisynthetic Single Penicillins Excluding Injectable Forms in the United States
Topics: General Pharmaceuticals, Manufacturing, Packaging & Detailing, Infectious Diseases
|
The 2007-2012 Outlook for Systemic Broad-And Medium-Spectrum Antibiotic Tetracyclines, Chlortetracycline, and Congeners in the United States
Topics: General Pharmaceuticals, Manufacturing, Packaging & Detailing, Infectious Diseases
|
The 2007-2012 Outlook for Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Pharmaceuticals in the United States
Topics: General Pharmaceuticals, Infectious Diseases
Regions: United States
|
The 2007-2012 Outlook for Urinary Antibacterials and Antiseptic Pharmaceutical Preparations in the United States
Topics: Infectious Diseases, Urology
|
Infectious Diseases: R&D Challenges and Market Drivers
Topics: General Biotechnology, Research & Development, Prescription Drugs, Drug Discovery, Infectious Diseases
Regions: Global
|
Avian Influenza: The Threatening Pandemic
Topics: Public Health, Disease Management, Vaccines, Infectious Diseases
Regions: Global
|
Tuberculosis: Trends, Challenges, and Opportunities in a Resurging Market
Topics: Infectious Diseases, Respiratory/Pulmonary
|
Partneringdesk Deals and Alliances In Infectious Diseases
Topics: Diseases & Conditions, Infectious Diseases
|
The Worldwide Influenza Market
Topics: Vaccines, Infectious Diseases, Respiratory/Pulmonary
Regions: Global
|
Conference Documentation: Superbugs & Superdrugs
Topics: Prescription Drugs, Infectious Diseases
|
The U.S. Market for Over-the-Counter Anti-Infectives
Topics: Over-the-Counter Drugs, Infectious Diseases
Regions: United States
|
Avian Influenza (AI): A Primer on the Science, Regulations and Policies
Topics: Public Health, Healthcare, Vaccines, Infectious Diseases
|
Commercial Insight: Antibacterials - Pharma Strikes Antibac
Topics: Infectious Diseases
|
The World Market for Anti-Infectives, Volume III: Antivirals
Topics: Prescription Drugs, Infectious Diseases
Regions: Global
|
Executive Summary: World Market for Anti-Infectives, Volume III: Antivirals
Topics: Prescription Drugs, Infectious Diseases
Regions: Global
|
The World Market for Anti-Infectives, Volume II: Antibacterials
Topics: Prescription Drugs, Infectious Diseases
|
Executive Summary:World Market for Anti-Infectives, Volume II: Antibacterials
Topics: Prescription Drugs, Infectious Diseases
Regions: Global
|
The 2006-2011 World Outlook for Systemic Broad-And Medium-Spectrum Antibiotic Tetracyclines, Chlortetracycline, and Congeners
Topics: General Pharmaceuticals, Manufacturing, Packaging & Detailing, Infectious Diseases
Regions: Global
|
The 2006-2011 World Outlook for Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Pharmaceuticals
Topics: General Pharmaceuticals, Infectious Diseases
|
The 2006-2011 World Outlook for Antitubercular Pharmaceuticals Excluding Tuberculostatic Isoniazid (isonicotinic Acid Hydrazide) Preparations
Topics: General Pharmaceuticals, Infectious Diseases
Regions: Global
|
The 2006-2011 World Outlook for Antimalarial (plasmodicide) Pharmaceuticals
Topics: General Pharmaceuticals, Infectious Diseases
Regions: Global
|
The 2006-2011 World Outlook for Antibacterial and Antiseptic Pharmaceuticals
Topics: General Pharmaceuticals, Infectious Diseases
|
The 2006-2011 World Outlook for Pharmaceutical Preparations for Human Use Affecting Parasitic and Infectious Diseases Excluding Diagnostics
Topics: General Pharmaceuticals, Diseases & Conditions, Infectious Diseases
|
The World Market for Anti-Infectives, Volume I: Antifungals
Topics: Prescription Drugs, Infectious Diseases
Regions: Global
|
Antibacterial Drug Resistance: Expanding Opportunities in the Hospital Market
Topics: Infectious Diseases
|
Executive Summary: World Market for Anti-Infectives, Volume I: Antifungals
Topics: Prescription Drugs, Infectious Diseases
Regions: Global
|
Advances in the Treatment of Serious Systemic Fungal Infections - An Update
Topics: Diseases & Conditions, Drug Discovery, Infectious Diseases
|
Antivirals Market Outlook: Market Analysis Of Future Growth And Leading Players By Sector
Topics: Prescription Drugs, Infectious Diseases
|
Antifungals: 2004 and Beyond
Topics: Infectious Diseases
|
